相关实验视频
Updated: May 27, 2025

08:36
In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
7.5K
将巨细胞代谢与瘤微环境中的功能联系起来
Robbie Jin1,2, Luke Neufeld1,2, Tracy L McGaha3,4
1Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Nature cancer
|February 17, 2025
概括
瘤相关巨细胞 (TAMs) 在固体瘤中丰富,阻碍了治疗反应. 它们的新陈代谢推动了免疫抑制,促进了瘤生长和转移,突出了癌症治疗的关键目标.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 代谢过程中的代谢.
背景情况:
- 巨细胞在固体瘤中普遍存在,与治疗结果和生存率差的相关性.
- 瘤微环境 (TME) 诱导特定的巨细胞极化状态,促进免疫逃避,瘤进展和转移.
- 与瘤相关的巨细胞 (TAM) 代谢被广泛重编程,支持这些亲瘤的功能.
研究的目的:
- 审查TME内不同TAM功能状态及其潜在的代谢程序之间的联系.
- 讨论TAM代谢重编程如何影响瘤进展和治疗耐药性.
- 探索旨在调节TAMs的治疗策略的代谢效应.
主要方法:
- 文献综述侧重于巨细胞生物学,瘤微环境和癌症代谢.
- 对TAM两极化和代谢途径的当前研究进行分析.
- 对针对TAM代谢的治疗干预措施的研究结果的综合.
主要成果:
- 确定了特定的代谢途径,可以在TME中维持不同的TAM功能状态.
- TAM代谢重编程是免疫抑制和瘤生长的关键驱动因素.
- 针对TAM代谢的治疗干预措施显示了改善癌症治疗结果的潜力.
结论:
- 了解TAM代谢程序对于破译它们在癌症中的作用至关重要.
- 针对TAM新陈代谢提供了一个有希望的策略,以克服治疗耐药性并改善患者的生存率.
- 对TAM代谢依赖性的进一步研究可以指导新型抗癌疗法的开发.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Immune Surveillance by NK Cells and Phagocytes
1.2K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.2K
Phagocytosis of Apoptotic Cells
3.5K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
3.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K

